<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-diseases-06-00106" class="ref">
 <label class="label">53.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Hwang</surname>
    <given-names class="given-names">M.K.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kang</surname>
    <given-names class="given-names">N.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Heo</surname>
    <given-names class="given-names">Y.S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lee</surname>
    <given-names class="given-names">K.W.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Lee</surname>
    <given-names class="given-names">H.J.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha</article-title>
  <source class="source">Biochem. Pharmacol.</source>
  <year class="year">2009</year>
  <volume class="volume">77</volume>
  <fpage class="fpage">1213</fpage>
  <lpage class="lpage">1222</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1016/j.bcp.2008.12.021</pub-id>
  <?supplied-pmid 19174152?>
  <pub-id pub-id-type="pmid" class="pub-id">19174152</pub-id>
 </element-citation>
</ref>
